Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL.
Miami Transplant Institute, Jackson Health System, Miami, FL.
Transplantation. 2020 Dec;104(12):2538-2546. doi: 10.1097/TP.0000000000003147.
The aging of liver transplant (LT) recipients, the weighting of the model for end-stage liver disease score, and the increased prevalence of nonalcoholic steatohepatitis has led to an increased number of older LT recipients with pre-LT chronic kidney disease (CKD). There are limited data on the impact of increased recipient age on post-simultaneous liver-kidney (SLK) transplant outcomes among patients with CKD, leading some centers to employ subjective age cutoffs for potential SLK recipients.
We evaluated United Network for Organ Sharing data of adult SLK recipients from February 27, 2002, to December 31, 2018, restricted to recipients with ≥90 days of waiting time and CKD (estimated glomerular filtration rate persistently <60 mL/min/1.73 m2 for ≥90 d using the modification of diet in renal disease-4 equation). We fit mixed-effects Cox regression models (center as random effect) to evaluate the association of recipient age and patient survival.
Among 3146 SLK recipients with CKD, nearly two-thirds were 50-64 years of age, while 465 (14.8%) and 93 (3.0%) were 65-69 years and ≥70 years, respectively. Compared with nondiabetic SLK recipients aged 50-59 years, SLK recipients ≥70 years of age without diabetes (hazard ratio, 1.97; 95% CI, 1.20-3.23; P = 0.007) and with diabetes (hazard ratio, 1.90; 95% CI, 1.16-3.09; P = 0.01) had higher mortality compared with the reference group. In absolute terms, SLK recipients ≥70 years of age had 25% lower patient survival at 5 years compared to recipients aged 40-49 years.
Although careful selection is required of any SLK recipient, especially those with increased comorbidities, there are no objective data to justify a specific age cutoff <70 years among potential SLK recipients with CKD.
肝移植(LT)受者的老龄化、终末期肝病模型评分的权重增加以及非酒精性脂肪性肝炎的患病率增加,导致越来越多的 LT 受者在 LT 前患有慢性肾脏病(CKD)。对于 CKD 患者,增加受者年龄对 SLK 移植后结局的影响数据有限,这导致一些中心对潜在的 SLK 受者采用主观年龄截止值。
我们评估了 2002 年 2 月 27 日至 2018 年 12 月 31 日期间 United Network for Organ Sharing 数据中成人 SLK 受者的资料,受者的入选标准为:等待时间≥90 天,CKD(采用改良肾脏病饮食研究-4 方程计算肾小球滤过率持续<60ml/min/1.73m2 持续≥90d)。我们使用混合效应 Cox 回归模型(以中心为随机效应)来评估受者年龄与患者生存率的关系。
在 3146 例 CKD 的 SLK 受者中,近三分之二的年龄在 50-64 岁之间,465 例(14.8%)和 93 例(3.0%)的年龄分别为 65-69 岁和≥70 岁。与 50-59 岁无糖尿病的非糖尿病 SLK 受者相比,≥70 岁无糖尿病(危险比,1.97;95%置信区间,1.20-3.23;P=0.007)和有糖尿病(危险比,1.90;95%置信区间,1.16-3.09;P=0.01)的 SLK 受者死亡率更高。从绝对值来看,与 40-49 岁受者相比,≥70 岁的 SLK 受者 5 年生存率降低 25%。
尽管需要对任何 SLK 受者进行仔细选择,尤其是那些合并症较多的受者,但对于患有 CKD 的潜在 SLK 受者,没有客观数据支持 70 岁以下的特定年龄截止值。